MiR-1247-3p Targets STAT5A to Inhibit Lung Adenocarcinoma Cell Migration and Chemotherapy Resistance

Overview

Journal J Cancer

Specialty Oncology

Date 2022 May 6

PMID 35517418

Authors

Jiansheng Lin

Xinyang Zheng

Xikun Tian

Jun Guan

Haizhan Shi

Affiliations

Soon will be listed here.

Abstract

Although several advancements have been achieved in research and treatment of lung adenocarcinoma in the past few years, the mechanism concerning cancerous cell migration and the cause of chemoresistance remains ambiguous. This research aimed to explore the impact of miR-1247-3p in lung adenocarcinoma. The mRNA expression of miR-1247-3p and STAT5A were conducted with qRT-PCR. Lentiviral vectors containing miR-1247-3p mimics and inhibitors were constructed. Cell migration were examined using Transwell assay. To observe chemotherapy resistance, Docetaxel, Doxorubicin, and Gefitinib were used. DIANA, miRDB, and TargetScan databases were applied to detect target genes. The binding sites were verified by double luciferase assay. Low expression of miR-1247-3p was observed in lung adenocarcinoma tissues and cell lines. Its expression was lower in advanced stages. Cell migration of lung adenocarcinoma was inhibited by miR-1247-3p, and it could negatively regulate the process of chemoresistance. miR-1247-3p directly binds to 3' UTR of STAT5A mRNA, and it functions via targeting STAT5A. miR-1247-3p acted as a potential governor monitoring cell migration and chemotherapy resistance of LUAD by interacting with STAT5A. It has the potential to be exploited as novel therapeutic target for LUAD in the future.

Citing Articles

miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer.

Wang D, Wang J, Yao F, Xie Z, Wu J, Chen H PLoS One. 2024; 19(12):e0309979.

PMID: 39739897 PMC: 11687890. DOI: 10.1371/journal.pone.0309979.

CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.

Li Y, Yang H, Li A, Chen B, Wang Y, Song Z Oncogene. 2024; 43(49):3570-3585.

PMID: 39402372 DOI: 10.1038/s41388-024-03188-w.

Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1.

Liu Z, Du D, Zhang S Cancer Biol Ther. 2023; 25(1):2290033.

PMID: 38073044 PMC: 10761019. DOI: 10.1080/15384047.2023.2290033.

Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma.

Limbu S, McCloskey K PLoS One. 2023; 18(11):e0294171.

PMID: 37948380 PMC: 10637681. DOI: 10.1371/journal.pone.0294171.

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells.

Maharati A, Moghbeli M Cell Div. 2023; 18(1):11.

PMID: 37480054 PMC: 10362644. DOI: 10.1186/s13008-023-00093-8.

References

Dho S, Kim J, Lee K, Kwon E, Lim J, Kim C . STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells. Exp Cell Res. 2016; 351(1):51-58. DOI: 10.1016/j.yexcr.2016.12.020. View

Lopez-Huerta E, Fuentes-Panana E . A Bioinformatic Pipeline Places STAT5A as a miR-650 Target in Poorly Differentiated Aggressive Breast Cancer. Int J Mol Sci. 2020; 21(20). PMC: 7589888. DOI: 10.3390/ijms21207720. View

Wu C, Sundararajan V, Sheu B, Huang R, Wei L . Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity. Cancers (Basel). 2019; 12(1). PMC: 7017004. DOI: 10.3390/cancers12010024. View

Chueh F, Chang Y, Wu S, Yu C . Signal transducer and activator of transcription 5a (STAT5a) represses mitochondrial gene expression through direct binding to mitochondrial DNA. Biochem Biophys Res Commun. 2020; 527(4):974-978. DOI: 10.1016/j.bbrc.2020.04.152. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Fang T, Lv H, Lv G, Li T, Wang C, Han Q . Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018; 9(1):191. PMC: 5768693. DOI: 10.1038/s41467-017-02583-0. View

Lamberti G, Andrini E, Sisi M, Rizzo A, Parisi C, Di Federico A . Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma. Crit Rev Oncol Hematol. 2020; 156:103119. DOI: 10.1016/j.critrevonc.2020.103119. View

Li H, Ma X, Xiao D, Jia Y, Wang Y . Expression of DEC2 enhances chemosensitivity by inhibiting STAT5A in gastric cancer. J Cell Biochem. 2018; 120(5):8447-8456. DOI: 10.1002/jcb.28131. View

Wang T, Zhong H, Zhang W, Wen J, Yi Z, Li P . STAT5a induces endotoxin tolerance by alleviating pyroptosis in kupffer cells. Mol Immunol. 2020; 122:28-37. DOI: 10.1016/j.molimm.2020.03.016. View

10.

Avgeris M, Panoutsopoulou K, Papadimitriou M, Scorilas A . Circulating exosomal miRNAs: clinical significance in human cancers. Expert Rev Mol Diagn. 2019; 19(11):979-995. DOI: 10.1080/14737159.2019.1673732. View

11.

Maranto C, Udhane V, Hoang D, Gu L, Alexeev V, Malas K . STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. Clin Cancer Res. 2018; 24(8):1917-1931. PMC: 6036914. DOI: 10.1158/1078-0432.CCR-17-2768. View

12.

Jiang Y, Tao Y, Zhang X, Wei X, Li M, He X . Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinoma. Mol Oncol. 2020; 15(2):710-724. PMC: 7858139. DOI: 10.1002/1878-0261.12846. View

13.

Yue C, Ma H, Zhou Y . Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. PeerJ. 2019; 7:e8128. PMC: 6886493. DOI: 10.7717/peerj.8128. View

14.

Wei Q, Yao J, Yang Y . MicroRNA-1247 inhibits the viability and metastasis of osteosarcoma cells via targeting NRP1 and mediating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci. 2019; 23(17):7266-7274. DOI: 10.26355/eurrev_201909_18831. View

15.

Arbour K, Riely G . Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. JAMA. 2019; 322(8):764-774. DOI: 10.1001/jama.2019.11058. View

16.

Guo Z, Tang Y, Fu Y, Wang J . Decreased expression of STAT5A predicts poor prognosis in osteosarcoma. Pathol Res Pract. 2019; 215(3):519-524. DOI: 10.1016/j.prp.2019.01.008. View

17.

Zhang P, Fan C, Du J, Mo X, Zhao Q . Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer. Int J Exp Pathol. 2018; 99(4):199-205. PMC: 6157300. DOI: 10.1111/iep.12287. View

18.

Zhang R, Zhou W, Yu Z, Yang L, Liu G, Yu H . miR-1247-3p mediates apoptosis of cerebral neurons by targeting caspase-2 in stroke. Brain Res. 2019; 1714:18-26. DOI: 10.1016/j.brainres.2019.02.020. View

19.

Qi X, Qi C, Qin B, Kang X, Hu Y, Han W . Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Front Oncol. 2020; 10:541330. PMC: 7538811. DOI: 10.3389/fonc.2020.541330. View

20.

Lee K, Park K, Hwang J, Lee M, Yoon D, Ryu H . Inhibition of STAT5A promotes osteogenesis by DLX5 regulation. Cell Death Dis. 2018; 9(11):1136. PMC: 6235898. DOI: 10.1038/s41419-018-1184-7. View